About Celecure
News
Pipeline
Our Team
Partnering with Celecure
Careers at Celecure
Contact
Celecure continues as a key partner in Competence Centre for Cancer Research
03.06.09
Today President of the Republic of Estonia Toomas Hendrik Ilves and representatives from Ministry of Economic Affairs and Communication and Enterprise Estonia awarded Competence Centre for Cancer Research a 6-year grant in grant decision delivery ceremony. The aim of the Competence Centre for Cancer Research is to improve the quality of cancer therapy by developing and implementing new diagnostic platforms and offering the pharmaceutical industry new cancer drug candidates. Beside Celecure the following organizations form the consortium:
Tallinn University of Technology, University of Tartu, North Estonia Medical Centre, Cambrex Tallinn Ltd, Kevelt Ltd, Protobios, Baltic Technology Development Ltd, EPhaG Ltd, Quattromed HTI Laboratories and TFS Trial Form Support International AB from Sweden.
« back
 www: aasa.ee